TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

7.90$ +8.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 227 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
75 242 157 138 136 155 215 466 414 314 226 227
43 184 91 74 75 87 114 332 213 112 46 133
40 172 76 60 53 62 100 292 179 76 40 3.0
40 172 76 60 53 62 100 307 193 76 40 3.0
1.2 9.8 11 1.1 0.9 16 1.2 1.5 2.7 26 0.4 1.8
0.1 0.1 0.1 0.1 0.1 7.4 11 20 14 0.0
6.0 15 26 26 25 26 60 91 133
18 23 22 23 23 23 25 25 25 25 24 24
6.8 19 16 32 12 11 11 8.5 6.2 4.4 3.4 3.0
52 172 196 214 311 387 426 418 468 462 533 505
9.2 29 41 56 68 122 130 157 189 256 221 323
1.3 0.1 0.1 21 0.1 2.0 2.8 3.4 2.5 146 9.8 156
1.7 4.5 5.4 8.1 14 14 17 30 41 61 61 83
4.8 114 131 142 13 13 19 13 13 13 30
23 71 -39 -76 -175 -231 -211 48 -55 -148 -326 -271
-691 -779 -905 -1,026 -1,177 -1,285 -1,466 -1,490 -1,710 -1,956 -2,183 -2,183
3.0 3.9 4.4 4.9 5.5 6.7 8.6 11 14 18 21 30

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?